Loading...
Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review
Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...
Na minha lista:
| Udgivet i: | Clin Med Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Marshfield Clinic
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/ https://ncbi.nlm.nih.gov/pubmed/31160476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|